# Rybelsus (semaglutide): Dosage, Side Effects & Uses

Source: https://pepvault.app/drugs/rybelsus

Last updated: 2026-11-18

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Brand-name drugs](https://pepvault.app/drugs) Rybelsus

Brand-name drug · GLP-1 receptor agonist

# Rybelsus (semaglutide)

From the FDA label, read Nov 18, 2026 [Published by PepVault](https://pepvault.app/guides/how-we-research)

Rybelsus is a semaglutide tablet from Novo Nordisk, swallowed once a day instead of injected.

FDA approved it, with diet and exercise, to improve blood sugar control in adults with type 2 diabetes and to reduce the risk of major heart events in adults with type 2 diabetes at high risk of them.

- **Active ingredient:** [Semaglutide (oral)](https://pepvault.app/peptides/semaglutide-oral)
- **Maker:** Novo Nordisk
- **Class:** GLP-1 receptor agonist
- **FDA application:** [NDA 213051](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213051), first approved 2019

## What FDA approved it for

The heart claim comes from a 4-year outcomes trial in which 4,825 people took semaglutide tablets and 4,825 took placebo. Rybelsus is not approved for weight; the semaglutide tablet for weight is sold as Wegovy.

From the label: 2.1 Important Administration Instructions; 1 Indications and Usage; 6.1 Clinical Trials Experience.

## How it is supplied

Rybelsus’s forms and the doses each one gives, as the label lists them

| Form | Doses |
| --- | --- |
| Tablet | 3 mg, 7 mg, 14 mg |

From the label: 3 Dosage Forms and Strengths.

## The label’s dosing schedule

This is the dosing schedule as the FDA label states it. A prescriber sets the actual dose and when it changes; it is not an instruction to the reader.

### Rybelsus, once a day

Rybelsus’s steps as the label lays them out, lowest to highest; each bar’s height is its dose against the top dose. A dashed bar is a step the label allows only if more is needed.

Rybelsus, once a day: the steps on the label. Highest dose: 14 mg a day.

| Dose | When, on the label |
| --- | --- |
| 3 mg a day | Days 1 to 30 |
| 7 mg a day | Days 31 to 60 |
| 14 mg a day | From day 61, if more control is needed |

The 3 mg month is a warm-up for the stomach, not a treatment dose: the label says 3 mg does not control blood sugar. From day 61 the dose stays at 7 mg or, if blood sugar needs more help, goes to 14 mg.

People on the 0.5 mg weekly Ozempic injection can switch, starting 7 mg or 14 mg of Rybelsus a week after the last injection.

From the label: 2.2 Recommended Starting, Escalation and Maintenance Dosage of RYBELSUS and OZEMPIC Tablets; 2.4 Switching from OZEMPIC Injection to RYBELSUS or OZEMPIC Tablets.

## How it’s taken

Rybelsus works only if it is taken the way the label describes: first thing in the morning on an empty stomach, one tablet swallowed whole with a sip of plain water (4 ounces at most), and then a wait of 30 minutes or more before breakfast, coffee or other medicines. Other drinks are not allowed with it, and splitting, crushing or chewing the tablet is not allowed either.

Rybelsus and Ozempic tablets are both semaglutide, but their milligrams don’t match one for one: 7 mg of Rybelsus lines up with 4 mg of Ozempic tablets, and 14 mg with 9 mg. The label allows a switch after the first 30 days, starting the other tablet the next day.

From the label: 2.1 Important Administration Instructions; 2.3 Switching Between RYBELSUS and OZEMPIC Tablets.

<!--promo-->

PepVault for iPhone

## Keep your own record in PepVault

Log each dose on your schedule, with a reminder for the next one.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=brand-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## If a dose is missed

There is no catching up on Rybelsus: the label says a forgotten tablet is skipped and the next one taken the day after.

From the label: 2.1 Important Administration Instructions.

## Storage

Rybelsus is stored at 68°F to 77°F, with short spells from 59°F to 86°F allowed, and stays in the bottle it came in.

From the label: 16 How Supplied/Storage and Handling.

## Side effects and warnings

Adverse reactions in at least 5% of people on semaglutide tablets in the placebo-controlled trials (adults with type 2 diabetes). Percent of people.

| Reaction | Placebo | 7 mg | 14 mg |
| --- | --- | --- | --- |
| Nausea | 6 | 11 | 20 |
| Abdominal pain | 4 | 10 | 11 |
| Diarrhea | 4 | 9 | 10 |
| Decreased appetite | 1 | 6 | 9 |
| Vomiting | 3 | 6 | 8 |
| Constipation | 2 | 6 | 5 |

These figures come from 1,071 people who took the tablets for an average of 41.8 weeks; nausea was the most common, reported by 20% at 14 mg.

### The boxed warning

**Boxed warning: “RISK OF THYROID C-CELL TUMORS”**Rybelsus has the boxed warning shared by semaglutide products, on thyroid C-cell tumors: they appeared in rodents given semaglutide, and the label says the risk to people is unknown. The tablets are ruled out for anyone with a personal or family history of medullary thyroid carcinoma or with MEN 2.

### The other warnings

Beyond the box, the label warns about pancreatitis, diabetic eye complications, low blood sugar alongside insulin or sulfonylureas, kidney injury from dehydration, severe stomach effects, allergic reactions, gallbladder disease and aspiration during anesthesia.

From the label: 6.1 Clinical Trials Experience; Boxed Warning; 5 Warnings and Precautions.

## How Rybelsus differs from Ozempic and Wegovy

Rybelsus, Ozempic and Wegovy hold the same active ingredient, semaglutide. What sets them apart is on their labels: what each is approved for, the forms it comes in and how high its schedule goes.

Semaglutide brands, label against label

| Compared | [Rybelsus](https://pepvault.app/drugs/rybelsus) | [Ozempic](https://pepvault.app/drugs/ozempic) | [Wegovy](https://pepvault.app/drugs/wegovy) |
| --- | --- | --- | --- |
| Approved for | Type 2 diabetes; heart risk in type 2 diabetes | Type 2 diabetes; heart and kidney risk in type 2 diabetes | Weight reduction; heart risk with obesity; MASH (injection) |
| Forms | Tablet | Multi-dose pen; Single-dose prefilled syringe; Tablet | Single-dose pen; Single-dose syringe; FlexTouch pen; Tablet |
| Label’s dose range | 3 mg to 14 mg once a day | injection: 0.25 mg to 2 mg once a week; tablets: 1.5 mg to 9 mg once a day | injection: 0.25 mg to 7.2 mg once a week; tablets: 1.5 mg to 25 mg once a day |
| Top dose | 14 mg a day | 2 mg a week; 9 mg a day | 7.2 mg a week; 25 mg a day |
| Maker | Novo Nordisk | Novo Nordisk | Novo Nordisk |

[Ozempic vs Rybelsus: the two labels side by side](https://pepvault.app/drugs/compare/ozempic-vs-rybelsus)

## What else we have on semaglutide

### Semaglutide on PepVault

- [Semaglutide (oral) in the peptide library](https://pepvault.app/peptides/semaglutide-oral)
- [Semaglutide (oral): half-life](https://pepvault.app/peptides/semaglutide-oral/half-life)
- [Semaglutide (oral): side effects](https://pepvault.app/peptides/semaglutide-oral/side-effects)
- [Is Semaglutide (oral) legal? FDA, DEA and WADA status](https://pepvault.app/peptides/semaglutide-oral/legal-status)
- [Semaglutide (oral) dose guide](https://pepvault.app/lab/dosage/semaglutide-oral)

### Free tools

- [GLP-1 titration calculator](https://pepvault.app/tools/glp1-titration-calculator)
- [Peptide half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### The trials, in plain English

- [Semaglutide (oral): heart risk not higher than placebo in PIONEER 6](https://pepvault.app/research/semaglutide-oral-pioneer-6-2019)
- [Semaglutide (oral): smaller HbA1c drop than orforglipron in ACHIEVE-3](https://pepvault.app/research/semaglutide-achieve-3-2026)

### Brand against brand

- [Ozempic vs Rybelsus](https://pepvault.app/drugs/compare/ozempic-vs-rybelsus)

### Compound against compound

- [Semaglutide vs Semaglutide (oral)](https://pepvault.app/peptides/compare/semaglutide-vs-semaglutide-oral)
- [Orforglipron vs Semaglutide (oral)](https://pepvault.app/peptides/compare/orforglipron-vs-semaglutide-oral)

## Questions about Rybelsus

### How do you take Rybelsus?

Once a day in the morning on an empty stomach, swallowed whole with up to 4 ounces of plain water, then at least 30 minutes before any food, drink or other pills.

### What is the Rybelsus dosing schedule?

The label starts at 3 mg a day for 30 days, then 7 mg a day. From day 61, the dose stays at 7 mg or goes to 14 mg if more blood sugar control is needed. A prescriber sets it.

### Is Rybelsus the same as Ozempic?

Both are semaglutide from Novo Nordisk. Rybelsus is a daily tablet; Ozempic is a weekly injection and also a daily tablet with different strengths (7 mg of Rybelsus matches 4 mg of Ozempic tablets).

### What if I miss a Rybelsus dose?

The label says to skip it and take the next tablet the following day.

## Sources

- [RYBELSUS (semaglutide) tablets and OZEMPIC (semaglutide) tablets, for oral use, FDA label on DailyMed](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=27f15fac-7d98-4114-a2ec-92494a91da98) (version 14, published Aug 19, 2026; read Nov 18, 2026)
- [Drugs@FDA, NDA 213051](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213051) (Rybelsus, the tablets; application first approved 2019)

PepVault is not affiliated with Novo Nordisk. Rybelsus is a trademark of its owner.

<!--promo-->

PepVault for iPhone

## Keep your own record in PepVault

Log each dose on your schedule, with a reminder for the next one.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=brand-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Keep your own record in PepVault

Log each dose on your schedule, with a reminder for the next one.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=brand-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## More on semaglutide

### Semaglutide on PepVault

- [Semaglutide (oral) in the peptide library](https://pepvault.app/peptides/semaglutide-oral)
- [Semaglutide (oral): half-life](https://pepvault.app/peptides/semaglutide-oral/half-life)
- [Semaglutide (oral): side effects](https://pepvault.app/peptides/semaglutide-oral/side-effects)
- [Is Semaglutide (oral) legal? FDA, DEA and WADA status](https://pepvault.app/peptides/semaglutide-oral/legal-status)
- [Semaglutide (oral) dose guide](https://pepvault.app/lab/dosage/semaglutide-oral)

### Free tools

- [GLP-1 titration calculator](https://pepvault.app/tools/glp1-titration-calculator)
- [Peptide half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### The trials, in plain English

- [Semaglutide (oral): heart risk not higher than placebo in PIONEER 6](https://pepvault.app/research/semaglutide-oral-pioneer-6-2019)
- [Semaglutide (oral): smaller HbA1c drop than orforglipron in ACHIEVE-3](https://pepvault.app/research/semaglutide-achieve-3-2026)

<!--promo-->

PepVault for iPhone

## Keep your own record in PepVault

Log each dose on your schedule, with a reminder for the next one.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=brand-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## Brand-name drugs

- [Every brand, by ingredient](https://pepvault.app/drugs)
- [Ozempic](https://pepvault.app/drugs/ozempic)
- [Wegovy](https://pepvault.app/drugs/wegovy)
- [Ozempic vs Rybelsus](https://pepvault.app/drugs/compare/ozempic-vs-rybelsus)

## The library

- [Semaglutide (oral) in the peptide library](https://pepvault.app/peptides/semaglutide-oral)
- [The peptide reference library](https://pepvault.app/peptides)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it. PepVault is not affiliated with Novo Nordisk. Rybelsus is a trademark of its owner.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
